Announcements Trials
Browse Landscape

Phase

Phase NA 20Phase 2 7Phase EARLY_PHASE1 3Phase 3 2Phase 1/2 2Phase 1 2Phase 2/3 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Genitourinary 1

Conditions

Stomach Neoplasms 1Metaplasia 1Gastroesophageal Reflux 1Barrett Esophagus 1

Interventions

Gemcitabine 218Fluorouracil 142Oxaliplatin 132Capecitabine 122pembrolizumab 113Irinotecan 110Leucovorin 104Bevacizumab 98Nivolumab 80Cisplatin 80130-nm albumin-bound paclitaxel 80Cetuximab 79Radiotherapy 78Albumin-Bound Paclitaxel 59Sorafenib 56Paclitaxel 53Cyclophosphamide 50Carboplatin 47Magnetic Resonance Spectroscopy 44Specimen Handling 39Docetaxel 37Taxes 36fludarabine 34Radiation 34durvalumab 33Ipilimumab 33Erlotinib Hydrochloride 33Biopsy 33Radiosurgery 27Folfox protocol 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Endoscopy × Gastrointestinal × Clear all
NCT04454476 2024-07-31

Reversal of Preneoplastic Metaplasia in the Stomach With MEK Inhibitor

Vanderbilt-Ingram Cancer Center

Phase 1 Active not recruiting
15 enrolled
Gastrointestinal

Metaplasia, Stomach Neoplasms

NCT00573911 2013-01-17

Acid Reflux and Stromal Fibroblasts in Barrett's Esophagus

Mayo Clinic

Phase 1 Completed
16 enrolled
Gastrointestinal

Barrett Esophagus, Gastroesophageal Reflux

Data powered by HemOnc (CC BY 4.0) Colophon âš¡